Gall Matthew (CIK 1816194) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-05). Recent activity: Buy TNGX (40,000 shares), Sell ITOS (89,429 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | Buy | 40,000 | $0 |
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) | Chief Financial Officer | Sell | 89,429 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-05